 | • レポートコード：MRC2102QY9828 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の非ステロイド性抗炎症薬（NSAID）市場について種類別（アスピリン、イブプロフェン、ナプロキセン、ナブメトン、その他）、用途別（腰痛治療、変形性関節症治療、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・非ステロイド性抗炎症薬（NSAID）市場の概要 ・世界の主要地域別非ステロイド性抗炎症薬（NSAID）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の非ステロイド性抗炎症薬（NSAID）市場規模2015-2026：種類別（アスピリン、イブプロフェン、ナプロキセン、ナブメトン、その他） ・世界の非ステロイド性抗炎症薬（NSAID）市場規模2015-2026：用途別（腰痛治療、変形性関節症治療、その他） ・非ステロイド性抗炎症薬（NSAID）の米国市場規模2015-2020 ・非ステロイド性抗炎症薬（NSAID）のヨーロッパ市場規模2015-2020 ・非ステロイド性抗炎症薬（NSAID）の中国市場規模2015-2020 ・非ステロイド性抗炎症薬（NSAID）の日本市場規模2015-2020 ・非ステロイド性抗炎症薬（NSAID）の東南アジア市場規模2015-2020 ・非ステロイド性抗炎症薬（NSAID）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・非ステロイド性抗炎症薬（NSAID）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・非ステロイド性抗炎症薬（NSAID）の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Non-steroidal Anti-inflammatory Drugs（NSAID） Market
The global Non-steroidal Anti-inflammatory Drugs（NSAID） market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Non-steroidal Anti-inflammatory Drugs（NSAID） Scope and Market Size
The global Non-steroidal Anti-inflammatory Drugs（NSAID） market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-steroidal Anti-inflammatory Drugs（NSAID） market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Non-steroidal Anti-inflammatory Drugs（NSAID） market is segmented into
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Segment by Application, the Non-steroidal Anti-inflammatory Drugs（NSAID） market is segmented into
Back Pain Treatment
Osteoarthritis Treatment
Others
The Non-steroidal Anti-inflammatory Drugs（NSAID） market is analysed and market size information is provided by regions (countries). Segment by Application, the Non-steroidal Anti-inflammatory Drugs（NSAID） market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Non-steroidal Anti-inflammatory Drugs（NSAID） Market Share Analysis
Non-steroidal Anti-inflammatory Drugs（NSAID） market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Non-steroidal Anti-inflammatory Drugs（NSAID） business, the date to enter into the Non-steroidal Anti-inflammatory Drugs（NSAID） market, Non-steroidal Anti-inflammatory Drugs（NSAID） product introduction, recent developments, etc.
The major vendors covered:
Bayer
Novacap
Abbott
Pfizer
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
Glaxo Smith Kline
Reddy Pharmaceuticals
Johnson & Johnson
1 Non-steroidal Anti-inflammatory Drugs（NSAID） Market Overview
1.1 Non-steroidal Anti-inflammatory Drugs（NSAID） Product Scope
1.2 Non-steroidal Anti-inflammatory Drugs（NSAID） Segment by Type
1.2.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales by Type (2020-2026)
1.2.2 Aspirin
1.2.3 Ibuprofen
1.2.4 Naproxen
1.2.5 Nabumetone
1.2.6 Others
1.3 Non-steroidal Anti-inflammatory Drugs（NSAID） Segment by Application
1.3.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Comparison by Application (2020-2026)
1.3.2 Back Pain Treatment
1.3.3 Osteoarthritis Treatment
1.3.4 Others
1.4 Non-steroidal Anti-inflammatory Drugs（NSAID） Market Estimates and Forecasts (2015-2026)
1.4.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Growth Rate (2015-2026)
1.4.2 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue and Growth Rate (2015-2026)
1.4.3 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Price Trends (2015-2026)
2 Non-steroidal Anti-inflammatory Drugs（NSAID） Estimate and Forecast by Region
2.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Region (2015-2020)
2.2.2 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Market Share by Region (2015-2020)
2.3 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Non-steroidal Anti-inflammatory Drugs（NSAID） Estimates and Projections (2015-2026)
2.4.2 Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Estimates and Projections (2015-2026)
2.4.3 China Non-steroidal Anti-inflammatory Drugs（NSAID） Estimates and Projections (2015-2026)
2.4.4 Japan Non-steroidal Anti-inflammatory Drugs（NSAID） Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Non-steroidal Anti-inflammatory Drugs（NSAID） Estimates and Projections (2015-2026)
2.4.6 India Non-steroidal Anti-inflammatory Drugs（NSAID） Estimates and Projections (2015-2026)
3 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Competition Landscape by Players
3.1 Global Top Non-steroidal Anti-inflammatory Drugs（NSAID） Players by Sales (2015-2020)
3.2 Global Top Non-steroidal Anti-inflammatory Drugs（NSAID） Players by Revenue (2015-2020)
3.3 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-steroidal Anti-inflammatory Drugs（NSAID） as of 2019)
3.4 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Average Price by Company (2015-2020)
3.5 Manufacturers Non-steroidal Anti-inflammatory Drugs（NSAID） Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Non-steroidal Anti-inflammatory Drugs（NSAID） Players (Opinion Leaders)
4 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Market Size by Type
4.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Historic Market Review by Type (2015-2020)
4.1.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type (2015-2020)
4.1.2 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Market Share by Type (2015-2020)
4.1.3 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Price by Type (2015-2020)
4.2 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Forecast by Type (2021-2026)
4.2.2 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Forecast by Type (2021-2026)
4.2.3 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Price Forecast by Type (2021-2026)
5 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Market Size by Application
5.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Historic Market Review by Application (2015-2020)
5.1.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application (2015-2020)
5.1.2 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Market Share by Application (2015-2020)
5.1.3 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Price by Application (2015-2020)
5.2 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Forecast by Application (2021-2026)
5.2.2 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Forecast by Application (2021-2026)
5.2.3 Global Non-steroidal Anti-inflammatory Drugs（NSAID） Price Forecast by Application (2021-2026)
6 United States Non-steroidal Anti-inflammatory Drugs（NSAID） Market Facts & Figures
6.1 United States Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Company (2015-2020)
6.2 United States Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type (2015-2020)
6.3 United States Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application (2015-2020)
7 Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Market Facts & Figures
7.1 Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Company (2015-2020)
7.2 Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type (2015-2020)
7.3 Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application (2015-2020)
8 China Non-steroidal Anti-inflammatory Drugs（NSAID） Market Facts & Figures
8.1 China Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Company (2015-2020)
8.2 China Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type (2015-2020)
8.3 China Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application (2015-2020)
9 Japan Non-steroidal Anti-inflammatory Drugs（NSAID） Market Facts & Figures
9.1 Japan Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Company (3015-3030)
9.2 Japan Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type (2015-2020)
9.3 Japan Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application (2015-2020)
10 Southeast Asia Non-steroidal Anti-inflammatory Drugs（NSAID） Market Facts & Figures
10.1 Southeast Asia Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application (2015-2020)
11 India Non-steroidal Anti-inflammatory Drugs（NSAID） Market Facts & Figures
11.1 India Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Company (2015-2020)
11.2 India Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type (2015-2020)
11.3 India Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Non-steroidal Anti-inflammatory Drugs（NSAID） Business
12.1 Bayer
12.1.1 Bayer Corporation Information
12.1.2 Bayer Business Overview
12.1.3 Bayer Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer Non-steroidal Anti-inflammatory Drugs（NSAID） Products Offered
12.1.5 Bayer Recent Development
12.2 Novacap
12.2.1 Novacap Corporation Information
12.2.2 Novacap Business Overview
12.2.3 Novacap Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novacap Non-steroidal Anti-inflammatory Drugs（NSAID） Products Offered
12.2.5 Novacap Recent Development
12.3 Abbott
12.3.1 Abbott Corporation Information
12.3.2 Abbott Business Overview
12.3.3 Abbott Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Abbott Non-steroidal Anti-inflammatory Drugs（NSAID） Products Offered
12.3.5 Abbott Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Non-steroidal Anti-inflammatory Drugs（NSAID） Products Offered
12.4.5 Pfizer Recent Development
12.5 Geri-Care Pharmaceuticals
12.5.1 Geri-Care Pharmaceuticals Corporation Information
12.5.2 Geri-Care Pharmaceuticals Business Overview
12.5.3 Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs（NSAID） Products Offered
12.5.5 Geri-Care Pharmaceuticals Recent Development
12.6 Perrigo Company
12.6.1 Perrigo Company Corporation Information
12.6.2 Perrigo Company Business Overview
12.6.3 Perrigo Company Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Perrigo Company Non-steroidal Anti-inflammatory Drugs（NSAID） Products Offered
12.6.5 Perrigo Company Recent Development
12.7 Kopran
12.7.1 Kopran Corporation Information
12.7.2 Kopran Business Overview
12.7.3 Kopran Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Kopran Non-steroidal Anti-inflammatory Drugs（NSAID） Products Offered
12.7.5 Kopran Recent Development
12.8 Merck Sharp & Dohme
12.8.1 Merck Sharp & Dohme Corporation Information
12.8.2 Merck Sharp & Dohme Business Overview
12.8.3 Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs（NSAID） Products Offered
12.8.5 Merck Sharp & Dohme Recent Development
12.9 Sun Pharmaceutical Industries
12.9.1 Sun Pharmaceutical Industries Corporation Information
12.9.2 Sun Pharmaceutical Industries Business Overview
12.9.3 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs（NSAID） Products Offered
12.9.5 Sun Pharmaceutical Industries Recent Development
12.10 Glaxo Smith Kline
12.10.1 Glaxo Smith Kline Corporation Information
12.10.2 Glaxo Smith Kline Business Overview
12.10.3 Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs（NSAID） Products Offered
12.10.5 Glaxo Smith Kline Recent Development
12.11 Reddy Pharmaceuticals
12.11.1 Reddy Pharmaceuticals Corporation Information
12.11.2 Reddy Pharmaceuticals Business Overview
12.11.3 Reddy Pharmaceuticals Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Reddy Pharmaceuticals Non-steroidal Anti-inflammatory Drugs（NSAID） Products Offered
12.11.5 Reddy Pharmaceuticals Recent Development
12.12 Johnson & Johnson
12.12.1 Johnson & Johnson Corporation Information
12.12.2 Johnson & Johnson Business Overview
12.12.3 Johnson & Johnson Non-steroidal Anti-inflammatory Drugs（NSAID） Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Johnson & Johnson Non-steroidal Anti-inflammatory Drugs（NSAID） Products Offered
12.12.5 Johnson & Johnson Recent Development
13 Non-steroidal Anti-inflammatory Drugs（NSAID） Manufacturing Cost Analysis
13.1 Non-steroidal Anti-inflammatory Drugs（NSAID） Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs（NSAID）
13.4 Non-steroidal Anti-inflammatory Drugs（NSAID） Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Non-steroidal Anti-inflammatory Drugs（NSAID） Distributors List
14.3 Non-steroidal Anti-inflammatory Drugs（NSAID） Customers
15 Market Dynamics
15.1 Non-steroidal Anti-inflammatory Drugs（NSAID） Market Trends
15.2 Non-steroidal Anti-inflammatory Drugs（NSAID） Opportunities and Drivers
15.3 Non-steroidal Anti-inflammatory Drugs（NSAID） Market Challenges
15.4 Non-steroidal Anti-inflammatory Drugs（NSAID） Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Non-steroidal Anti-inflammatory Drugs（NSAID） Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Region (2015-2020)
Table 5. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Region (2015-2020)
Table 6. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Share by Region (2015-2020)
Table 8. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Share Forecast by Region (2021-2026)
Table 12. Global Non-steroidal Anti-inflammatory Drugs（NSAID） (MT) of Key Companies (2015-2020)
Table 13. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Share by Company (2015-2020)
Table 14. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Share by Company (2015-2020)
Table 16. Global Non-steroidal Anti-inflammatory Drugs（NSAID） by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-steroidal Anti-inflammatory Drugs（NSAID） as of 2019)
Table 17. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Non-steroidal Anti-inflammatory Drugs（NSAID） Manufacturing Sites and Area Served
Table 19. Manufacturers Non-steroidal Anti-inflammatory Drugs（NSAID） Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Non-steroidal Anti-inflammatory Drugs（NSAID） Players
Table 22. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Type (2015-2020)
Table 23. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Share by Type (2015-2020)
Table 24. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Price (MT) by Type (2015-2020)
Table 26. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Share by Type (2021-2026)
Table 27. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Share by Type (2021-2026)
Table 29. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Price (MT) by Type (2021-2026)
Table 30. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Application (2015-2020)
Table 31. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Share by Application (2015-2020)
Table 32. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Price (MT) by Application (2015-2020)
Table 34. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Application (2021-2026)
Table 35. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Share by Application (2021-2026)
Table 36. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Share by Application (2021-2026)
Table 38. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Price (MT) by Application (2021-2026)
Table 39. United States Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Company (2015-2020)
Table 40. United States Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Company (2015-2020)
Table 41. United States Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Type (2015-2020)
Table 42. United States Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type (2015-2020)
Table 43. United States Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Application (2015-2020)
Table 44. United States Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application (2015-2020)
Table 45. Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Company (2015-2020)
Table 46. Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Company (2015-2020)
Table 47. Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Type (2015-2020)
Table 48. Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type (2015-2020)
Table 49. Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Application (2015-2020)
Table 50. Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type (2015-2020)
Table 51. China Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Company (2015-2020)
Table 52. China Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Company (2015-2020)
Table 53. China Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Type (2015-2020)
Table 54. China Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type (2015-2020)
Table 55. China Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Application (2015-2020)
Table 56. China Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application (2015-2020)
Table 57. Japan Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Company (2015-2020)
Table 58. Japan Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Company (2015-2020)
Table 59. Japan Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Type (2015-2020)
Table 60. Japan Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type (2015-2020)
Table 61. Japan Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Application (2015-2020)
Table 62. Japan Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application (2015-2020)
Table 69. India Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Company (2015-2020)
Table 70. India Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Company (2015-2020)
Table 71. India Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Type (2015-2020)
Table 72. India Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type (2015-2020)
Table 73. India Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) by Application (2015-2020)
Table 74. India Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application (2015-2020)
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Bayer Non-steroidal Anti-inflammatory Drugs（NSAID） Product
Table 79. Bayer Recent Development
Table 80. Novacap Corporation Information
Table 81. Novacap Description and Business Overview
Table 82. Novacap Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Novacap Non-steroidal Anti-inflammatory Drugs（NSAID） Product
Table 84. Novacap Recent Development
Table 85. Abbott Corporation Information
Table 86. Abbott Description and Business Overview
Table 87. Abbott Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Abbott Non-steroidal Anti-inflammatory Drugs（NSAID） Product
Table 89. Abbott Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Pfizer Non-steroidal Anti-inflammatory Drugs（NSAID） Product
Table 94. Pfizer Recent Development
Table 95. Geri-Care Pharmaceuticals Corporation Information
Table 96. Geri-Care Pharmaceuticals Description and Business Overview
Table 97. Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs（NSAID） Product
Table 99. Geri-Care Pharmaceuticals Recent Development
Table 100. Perrigo Company Corporation Information
Table 101. Perrigo Company Description and Business Overview
Table 102. Perrigo Company Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Perrigo Company Non-steroidal Anti-inflammatory Drugs（NSAID） Product
Table 104. Perrigo Company Recent Development
Table 105. Kopran Corporation Information
Table 106. Kopran Description and Business Overview
Table 107. Kopran Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Kopran Non-steroidal Anti-inflammatory Drugs（NSAID） Product
Table 109. Kopran Recent Development
Table 110. Merck Sharp & Dohme Corporation Information
Table 111. Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Merck Sharp & Dohme Description and Business Overview
Table 113. Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs（NSAID） Product
Table 114. Merck Sharp & Dohme Recent Development
Table 115. Sun Pharmaceutical Industries Corporation Information
Table 116. Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Sun Pharmaceutical Industries Description and Business Overview
Table 118. Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs（NSAID） Product
Table 119. Sun Pharmaceutical Industries Recent Development
Table 120. Glaxo Smith Kline Corporation Information
Table 121. Glaxo Smith Kline Description and Business Overview
Table 122. Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs（NSAID） Product
Table 124. Glaxo Smith Kline Recent Development
Table 125. Reddy Pharmaceuticals Corporation Information
Table 126. Reddy Pharmaceuticals Description and Business Overview
Table 127. Reddy Pharmaceuticals Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Reddy Pharmaceuticals Non-steroidal Anti-inflammatory Drugs（NSAID） Product
Table 129. Reddy Pharmaceuticals Recent Development
Table 130. Johnson & Johnson Corporation Information
Table 131. Johnson & Johnson Description and Business Overview
Table 132. Johnson & Johnson Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Johnson & Johnson Non-steroidal Anti-inflammatory Drugs（NSAID） Product
Table 134. Johnson & Johnson Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Non-steroidal Anti-inflammatory Drugs（NSAID） Distributors List
Table 138. Non-steroidal Anti-inflammatory Drugs（NSAID） Customers List
Table 139. Non-steroidal Anti-inflammatory Drugs（NSAID） Market Key Trends
Table 140. Non-steroidal Anti-inflammatory Drugs（NSAID） Key Opportunities and Drivers
Table 141. Non-steroidal Anti-inflammatory Drugs（NSAID） Market Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-steroidal Anti-inflammatory Drugs（NSAID） Product Picture
Figure 2. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Market Share by Application in 2020 & 2026
Figure 6. Back Pain Treatment Examples
Figure 7. Osteoarthritis Treatment Examples
Figure 8. Others Examples
Figure 9. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Non-steroidal Anti-inflammatory Drugs（NSAID） Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Non-steroidal Anti-inflammatory Drugs（NSAID） Players Market Share by Revenue in Non-steroidal Anti-inflammatory Drugs（NSAID） 2015 & 2019
Figure 27. Non-steroidal Anti-inflammatory Drugs（NSAID） Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Share by Type (2015-2020)
Figure 29. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Share by Application (2015-2020)
Figure 31. Global Non-steroidal Anti-inflammatory Drugs（NSAID） Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type in 2019
Figure 33. United States Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type in 2019
Figure 34. Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Company in 2019
Figure 35. Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type in 2019
Figure 36. Europe Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application in 2019
Figure 37. China Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Company in 2019
Figure 38. China Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type in 2019
Figure 39. China Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application in 2019
Figure 40. Japan Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Company in 2019
Figure 41. Japan Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type in 2019
Figure 42. Japan Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application in 2019
Figure 43. Southeast Asia Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Company in 2019
Figure 44. Southeast Asia Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type in 2019
Figure 45. Southeast Asia Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application in 2019
Figure 46. India Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Company in 2019
Figure 47. India Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Type in 2019
Figure 48. India Non-steroidal Anti-inflammatory Drugs（NSAID） Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Non-steroidal Anti-inflammatory Drugs（NSAID）
Figure 51. Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs（NSAID）
Figure 52. Non-steroidal Anti-inflammatory Drugs（NSAID） Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
抗消化性潰瘍治療薬の世界市場レポート2020 Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. China’s anti-trust crackdown on foreign pharmaceutical companies has left many foreign investors in the healthcare industry…- ドライアイ治療薬の世界市場レポート2020 Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and contin…
- 海洋由来薬品の世界市場レポート2020 Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydroph…
- 麻酔薬・鎮痛薬の世界市場レポート2020 Market Analysis and Insights: Global Anaesthetic Drugs and Pain Drugs Market The global Anaesthetic Drugs and Pain Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Anaesthetic Drugs and Pain Drugs Scope and Market …
- トレプロスチニル薬の世界市場レポート2020 Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension. North America is the largest consumption place, with a consumption market share nearly 92% in 2018. Following North America, Europe are also very important market with the consumption market share of 6.8…